Skip to main content
. 2016 Dec 21;6:39485. doi: 10.1038/srep39485

Figure 3. Sensitivity analysis of association between CD44 polymorphisms and cancer risk.

Figure 3

Polymorphisms represented in (A) rs13347 under the allele contrast model and (B) rs11821102 under the heterozygous model.